A molecular proof of this link between oxidative stress and inflammation in the development of hypertension in mice was provided by genetic ablation of myelomonocytic cells, which prevented all adverse effects of angiotensin-II infusion, including increased blood pressure, endothelial dysfunction, vascular oxidative stress, and inflammation. Here, AGT is linked to endothelial dysfunction.